GeneDx Corp. (WGS)
73.72
1.72 (2.38%)
At close: Jan 15, 2025, 1:22 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -175.77M | -548.98M | -245.39M | -241.34M | -29.70M |
| Depreciation & Amortization | 35.83M | 59.31M | 21.81M | 11.73M | 6.41M |
| Stock-Based Compensation | -326.00K | 41.98M | 219.42M | 120.23M | 5.48M |
| Other Working Capital | -2.53M | -8.46M | 123.00K | -1.00M | 1.42M |
| Other Non-Cash Items | -721.00K | 141.53M | 1.62M | 2.40M | -176.00K |
| Deferred Income Tax | -926.00K | -49.12M | -195.97M | n/a | n/a |
| Change in Working Capital | -38.24M | 36.13M | 8.08M | 13.85M | -737.00K |
| Operating Cash Flow | -180.15M | -319.15M | -190.43M | -93.13M | -18.73M |
| Capital Expenditures | -5.71M | -14.32M | -20.79M | -31.97M | -15.46M |
| Acquisitions | -8.11M | -127.00M | n/a | n/a | n/a |
| Purchase of Investments | -47.67M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 17.77M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -1 | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -43.73M | -141.33M | -20.79M | -31.97M | -15.46M |
| Debt Repayment | 42.95M | -3.29M | -13.47M | 11.73M | -1.71M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 285.00K | 2.95M | 65.05M | 117.32M | 149.72M |
| Financial Cash Flow | 186.24M | 197.31M | 493.73M | 129.06M | 148.01M |
| Net Cash Flow | -37.72M | -263.17M | 282.51M | 3.95M | 113.83M |
| Free Cash Flow | -185.86M | -333.48M | -211.22M | -125.10M | -34.18M |